Global Feature
Big Pharma's Investment in Biologics
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Bristol-Myers Squibb, Novartis, GlaxoSmithKline, Sanofi, and Roche are among the companies expanding biologic-based manufacturing capacity.
Advertisement:
A Pragmatic Application of QbD: Turning Theory into Tangible Success
Live Webcast: Thursday, May 2, 2013 at 11:00 am EDT
Register Free at
 www.pharmtech.com/pragmatic
Biologics
The New Normal in Biotech Financing
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Financing to biotech companies in North America and Europe declined in 2012 as debt funding decreased and the IPO market remained weak.
Advertisement:
Trends in safe handling of potent compounds in pharmaceutical manufacturing processes
Live Webcast: Wednesday, May 15, 2013 at 11:00 AM EDT
Register Free at
 www.pharmtech.com/trends
Outsourcing
Strategic Partnering for Manufacturing
Jim Miller, president of PharmSource Information Services
Eisai and Biogen Idec pursue an innovative approach to capacity management.
Pharma Industry’s Global Health and Sustainability Forum
Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
Pharma Industry’s Global Health and Sustainability Forum
Pharma Industry Participates in Vaccine Initiatives
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
The Global Vaccine Action plan maps out a strategy to increase access and R&D for vaccines.
Advertisement:
Cleaning Validation: Science, Risk, and Novel Approaches to Testing
Live Webcast: Tuesday, June 4, 2013 at 11:00 am EDT
Register Free at
 www.pharmtech.com/testing
| 
